Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine (Q38431409)
Jump to navigation
Jump to search
scientific article published on 25 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine |
scientific article published on 25 April 2014 |
Statements
1 reference
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine (English)
1 reference
M M Amonkar
S Martin-Algarra
L V Demidov
V Goodman
K Grotzinger
P Haney
E Kämpgen
B Karaszewska
C Mauch
W H Miller
M Millward
B Mirakhur
S Swann
25 April 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference